ImmunologybioRxiv
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
J. M. Diez, C. Romero, J. Vergara Alert…·R. Gajardo
This study shows that currently available IVIG products neutralize SARS-CoV-2 and SARS-CoV in cell cultures but not MERS-CoV.
DOI 10.2217/imt-2020-0220